- Innovative platforms across key stages of TCE drug discovery, with real-world case studies on high-purity
production and fit-for-purpose in vitro & in vivo studies - Proven approaches to navigate key development challenges, such as structural complexity, CRS risks, and tumor heterogeneity
- Forward-looking strategies combining TCEs with immunomodulatory domains or checkpoint inhibitors
Brought to you by
